País: Estados Unidos
Idioma: inglés
Fuente: NLM (National Library of Medicine)
DANAZOL (UNII: N29QWW3BUO) (DANAZOL - UNII:N29QWW3BUO)
Lannett Company, Inc.
DANAZOL
DANAZOL 50 mg
ORAL
PRESCRIPTION DRUG
Endometriosis. Danazol capsules are indicated for the treatment of endometriosis amenable to hormonal management. Hereditary Angioedema. Danazol capsules are indicated for the prevention of attacks of angioedema of all types (cutaneous, abdominal, laryngeal) in males and females. Danazol capsules should not be administered to patients with: - Undiagnosed abnormal genital bleeding. - Markedly impaired hepatic, renal, or cardiac function. - Pregnancy (see WARNINGS ). - Breast feeding. - Porphyria-Danazol capsules can induce ALA synthetase activity and hence porphyrin metabolism. - Androgen-dependent tumor. - Active thrombosis or thromboembolic disease and history of such events. - Hypersensitivity to danazol.
Danazol Capsules USP, 50 mg are available as maize opaque/white opaque capsules imprinted with logo "LANNETT" on the cap and "1392" on the body and are supplied in: Bottles of 100 (NDC 0527-1392-01) Danazol Capsules USP, 100 mg are available as maize opaque/maize opaque capsules imprinted with logo "LANNETT" on the cap and "1368" on the body and are supplied in: Bottles of 100 (NDC 0527-1368-01) Danazol Capsules USP, 200 mg are available as orange opaque/orange opaque capsules imprinted with logo "LANNETT" on the cap and "1369" on the body and are supplied in: Bottles of 60 (NDC 0527-1369-06) Bottles of 100 (NDC 0527-1369-01) Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a well-closed container with a child-resistant closure as defined in the USP. Distributed by: Lannett Company, Inc. Philadelphia, PA 19136 CIB70495E Rev. 04/20
Abbreviated New Drug Application
DANAZOL- DANAZOL CAPSULE LANNETT COMPANY, INC. ---------- DANAZOL CAPSULES, USP RX ONLY DESCRIPTION Danazol is a synthetic steroid derived from ethisterone. It is a white to pale yellow crystalline powder, practically insoluble or insoluble in water, and sparingly soluble in alcohol. Chemically, danazol is 17α-Pregna-2,4-dien-20-yno [2,3-_d_]- isoxazol-17-ol. The molecular formula is C H NO . It has a molecular weight of 337.46 and the following structural formula: Danazol capsules for oral administration contain 50 mg, 100 mg or 200 mg danazol. _Inactive Ingredients:_ anhydrous lactose, lactose monohydrate, magnesium stearate, pregelatinized starch, sodium lauryl sulfate, talc. Capsule shells for 200 mg danazol contain D&C Yellow #10, FD&C Red #40, D&C Red #28, gelatin, and titanium dioxide. Capsule shells for 50 mg and 100 mg danazol contain D&C Yellow # 10, FD&C Red # 40, gelatin, and titanium dioxide. The capsule imprinting ink contains: shellac glaze in ethanol, iron oxide black, n-butyl alcohol, propylene glycol, ethanol, methanol, FD&C Blue No. 2 Aluminum Lake, FD&C Red No. 40 Aluminum Lake, FD&C Blue No. 1 Aluminum Lake, and D&C Yellow No. 10 Aluminum Lake. CLINICAL PHARMACOLOGY Danazol suppresses the pituitary-ovarian axis. This suppression is probably a 22 27 2 combination of depressed hypothalamic-pituitary response to lowered estrogen production, the alteration of sex steroid metabolism, and interaction of danazol with sex hormone receptors. The only other demonstrable hormonal effect is weak androgenic activity. Danazol depresses the output of both follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Recent evidence suggests a direct inhibitory effect at gonadal sites and a binding of danazol to receptors of gonadal steroids at target organs. In addition, danazol has been shown to significantly decrease IgG, IgM and IgA levels, as well as phospholipid and IgG isotope autoantibodies in patients with endometriosis and associated elevations of autoantibodies, suggesting this could be anothe Leer el documento completo